These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 21846189)
1. Radiofrequency ablation combined with liposomal quercetin to increase tumour destruction by modulation of heat shock protein production in a small animal model. Yang W; Ahmed M; Tasawwar B; Levchenko T; Sawant RR; Collins M; Signoretti S; Torchilin V; Goldberg SN Int J Hyperthermia; 2011; 27(6):527-38. PubMed ID: 21846189 [TBL] [Abstract][Full Text] [Related]
2. Combination radiofrequency (RF) ablation and IV liposomal heat shock protein suppression: reduced tumor growth and increased animal endpoint survival in a small animal tumor model. Yang W; Ahmed M; Tasawwar B; Levchenko T; Sawant RR; Torchilin V; Goldberg SN J Control Release; 2012 Jun; 160(2):239-44. PubMed ID: 22230341 [TBL] [Abstract][Full Text] [Related]
3. Effect of thermal dose on heat shock protein expression after radio-frequency ablation with and without adjuvant nanoparticle chemotherapies. Moussa M; Goldberg SN; Kumar G; Levchenko T; Torchilin V; Ahmed M Int J Hyperthermia; 2016 Dec; 32(8):829-841. PubMed ID: 27600101 [TBL] [Abstract][Full Text] [Related]
4. Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model? Yang W; Ahmed M; Elian M; Hady el-SA; Levchenko TS; Sawant RR; Signoretti S; Collins M; Torchilin VP; Goldberg SN Radiology; 2010 Dec; 257(3):685-96. PubMed ID: 20858851 [TBL] [Abstract][Full Text] [Related]
5. Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways. Solazzo SA; Ahmed M; Schor-Bardach R; Yang W; Girnun GD; Rahmanuddin S; Levchenko T; Signoretti S; Spitz DR; Torchilin V; Goldberg SN Radiology; 2010 Apr; 255(1):62-74. PubMed ID: 20160000 [TBL] [Abstract][Full Text] [Related]
6. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model. Goldberg SN; Girnan GD; Lukyanov AN; Ahmed M; Monsky WL; Gazelle GS; Huertas JC; Stuart KE; Jacobs T; Torchillin VP; Halpern EF; Kruskal JB Radiology; 2002 Mar; 222(3):797-804. PubMed ID: 11867804 [TBL] [Abstract][Full Text] [Related]
7. Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals. Ahmed M; Liu Z; Lukyanov AN; Signoretti S; Horkan C; Monsky WL; Torchilin VP; Goldberg SN Radiology; 2005 May; 235(2):469-77. PubMed ID: 15858089 [TBL] [Abstract][Full Text] [Related]
8. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time. Ahmed M; Lukyanov AN; Torchilin V; Tournier H; Schneider AN; Goldberg SN J Vasc Interv Radiol; 2005 Oct; 16(10):1365-71. PubMed ID: 16221908 [TBL] [Abstract][Full Text] [Related]
9. RF ablation with adjuvant therapy: comparison of external beam radiation and liposomal doxorubicin on ablation efficacy in an animal tumor model. Solazzo S; Mertyna P; Peddi H; Ahmed M; Horkan C; Goldberg SN Int J Hyperthermia; 2008 Nov; 24(7):560-7. PubMed ID: 18608584 [TBL] [Abstract][Full Text] [Related]
11. Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation. Ahmed M; Monsky WE; Girnun G; Lukyanov A; D'Ippolito G; Kruskal JB; Stuart KE; Torchilin VP; Goldberg SN Cancer Res; 2003 Oct; 63(19):6327-33. PubMed ID: 14559820 [TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation-induced upregulation of hypoxia-inducible factor-1α can be suppressed with adjuvant bortezomib or liposomal chemotherapy. Moussa M; Goldberg SN; Kumar G; Sawant RR; Levchenko T; Torchilin V; Ahmed M J Vasc Interv Radiol; 2014 Dec; 25(12):1972-82. PubMed ID: 25439675 [TBL] [Abstract][Full Text] [Related]
13. Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model. Soundararajan A; Dodd GD; Bao A; Phillips WT; McManus LM; Prihoda TJ; Goins BA Radiology; 2011 Dec; 261(3):813-23. PubMed ID: 22025735 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous tumor ablation: reduced tumor growth with combined radio-frequency ablation and liposomal doxorubicin in a rat breast tumor model. D'Ippolito G; Ahmed M; Girnun GD; Stuart KE; Kruskal JB; Halpern EF; Goldberg SN Radiology; 2003 Jul; 228(1):112-8. PubMed ID: 12808127 [TBL] [Abstract][Full Text] [Related]
15. Combination radiofrequency thermal ablation and adjuvant IV liposomal doxorubicin increases tissue coagulation and intratumoural drug accumulation. Ahmed M; Goldberg SN Int J Hyperthermia; 2004 Nov; 20(7):781-802. PubMed ID: 15675672 [TBL] [Abstract][Full Text] [Related]
16. Radio-frequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model. Monsky WL; Kruskal JB; Lukyanov AN; Girnun GD; Ahmed M; Gazelle GS; Huertas JC; Stuart KE; Torchilin VP; Goldberg SN Radiology; 2002 Sep; 224(3):823-9. PubMed ID: 12202721 [TBL] [Abstract][Full Text] [Related]
17. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intratumoral doxorubicin injection in a rat breast tumor model. Goldberg SN; Saldinger PF; Gazelle GS; Huertas JC; Stuart KE; Jacobs T; Kruskal JB Radiology; 2001 Aug; 220(2):420-7. PubMed ID: 11477246 [TBL] [Abstract][Full Text] [Related]
18. Nanodrug-enhanced radiofrequency tumor ablation: effect of micellar or liposomal carrier on drug delivery and treatment efficacy. Moussa M; Goldberg SN; Kumar G; Sawant RR; Levchenko T; Torchilin VP; Ahmed M PLoS One; 2014; 9(8):e102727. PubMed ID: 25133740 [TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation (RFA)-induced systemic tumor growth can be reduced by suppression of resultant heat shock proteins. Ahmed M; Kumar G; Gourevitch S; Levchenko T; Galun E; Torchilin V; Goldberg SN Int J Hyperthermia; 2018 Nov; 34(7):934-942. PubMed ID: 29631466 [TBL] [Abstract][Full Text] [Related]
20. Heat shock protein inhibitor, quercetin, as a novel adjuvant agent to improve radiofrequency ablation-induced tumor destruction and its molecular mechanism. Yang W; Cui M; Lee J; Gong W; Wang S; Fu J; Wu G; Yan K Chin J Cancer Res; 2016 Feb; 28(1):19-28. PubMed ID: 27041924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]